Fritextsökning
Innehållstyper
-
Biotech goes white and bright
White biotech could become Denmark's next blossoming business area.
-
Young, bright and committed to labtech
Ghazal Voghoui recently bought her first apartment and finally settled in Stockholm again. Last year, she finished her law studies and she is relieved to be bac...
-
Vitrolife wants to acquire Medicult
The Swedish company Vitrolife intends to make en exchange offer to the shareholders of the Danish company Medicult to acquire all outstanding shares in the company.
-
Orion cuts 205 jobs
The Finnish company Orion has completed its statutory negotiations. By this, personnel will be reduced by about 205 in Finland.
-
Swiss allergy therapy convinces
Cytos Biotechnology presents promising results in a study of a new therapy against allergy and asthma.
-
Så kan life science-bolag locka investerare
Finns det något framgångsrecept för life science-bolag som vill få in kapital från investerare? Ja, faktiskt. Life Science Sweden talar med en av arrangörerna b...
-
Finnish Innovation Fund gets new leader
The Supervisory Board of the Finnish Innovation Fund Sitra has appointed members of the Board, including a new president.
-
"Omvärlden börjar få upp ögonen för The Swedish Life Science Smorgasbord"
En essentiell aktiv ingrediens är politiskt ledarskap på högsta nivå, men ”cost of goods” tycks vara en begränsande faktor, skriver Sweden Bios vd Jonas Ekstrand.
-
Bio-Linux goes global
Recently the NEBC Bio-Linux Version 5.0 was released, a one-stop shop for bioinformatics tools in a Linux context.
-
Positivt besked för Selincro
Lundbecks läkemedel för att minska alkoholkonsumtionen hos personer som dricker för mycket, rekommenderas av CHMP.
-
Abbott expands by acquisition
An acquisition gives Abbott a leadership position in another large and growing medical device segment.
-
Måttligt med salt ok för hälsan
Salt i maten är inte så farligt för hälsan som vi tidigare trott visar en omfattande studie som publiceras i The Lancet.
-
Meda gets access to Asia
The biotech giant Meda has recently acquires world-wide rights to the cancer breakthrough pain drug Onsolis.
-
Norwegian cancer therapy leaves phase II
New clinical results from Algeta highlights the potential of Alpharadin to treat bone metastases in major cancer indications.
-
Top modern lab to Sahlgrenska
The Sahlgrenska Science Park will soon open the doors to a brand new wet laboratory.
-
NIH-pengar till Umeåforskning
Fredrik Almqvist, Umeå universitet, och hans amerikanska forskarkollega får 24 miljoner kronor från National institutes of health, NIH, till tuberkulosforskning.
-
"An open mind is the key to successful meetings"
Meeting in person is irreplaceble when it comes to finding a new partner. Johan Ohlsson at Venture Valuation is happy with his meetings at Biotech Forum so far ...
-
Pfizer buys Swiss vaccines
Pfizer executes commercial license agreements for novel human vaccines based on the Swiss company Cytos Biotechnology's Immunodrug technology.
-
Positive combined cancer therapy
Topotarget announces positive data with new treatment against colorectal cancer.
-
Ledarskap på agendan
Under en heldag bollade branschpersonligheter ledarskapsfrågor och erfarenheter från kommersialisering på högsta nivå.
-
Re-painting the big pig-ture
Why do tame pigs show such variety in colouring, when their wild relatives are so plain? Swedish researchers know who is to blame. But the big question is why.
-
Medtech giant separates
Due to the global economic situation, the medtech companies Q-Med and the Palomar Medical Technologies has terminated its international agreement.
-
New Nordic nutrition collaboration
Scandinavian Clinical Nutrition has recently signed a unique Nordic distribution agreement.
-
KI-forskare ser koppling mellan adhd och demens
En studie vid Karolinska institutet har funnit en koppling mellan adhd och demens över generationer.
BREAKING